pharmaphorum
NOVEMBER 29, 2021
A web-based digital tool called Helix could help clinicians identify patients with prostate cancer who would benefit from genetic testing and counselling, according to researchers in the US. ” The post Helix web tool guides prostate cancer genetic testing appeared first on. .
Medical Xpress
FEBRUARY 24, 2023
Although genetic mutations in BRCA1 or BRCA2 are associated with a younger onset of breast and ovarian cancer, women with these genetic mutations continue to face a high risk of cancer incidence after age 50, even if they have not been previously diagnosed with cancer. Bloomberg Faculty of Nursing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bioengineer
JULY 15, 2021
New Rochelle, NY, July 14, 2021-Firsthand reports from nurses in correctional facilities detail the challenges they faced during the COVID-19 pandemic. These firsthand accounts are reported in a special issue on correctional nursing in the Journal of Correctional Health Care. Credit: Mary Ann Liebert, Inc., publishers. liebertpub.
pharmaphorum
DECEMBER 2, 2021
The aims of Babylon’s app go further than to provide an easy-access doctor and include leveraging patient data to provide doctors and nurses with user-inputted information to inform decision-making processes. Using patients’ genetic data. Tapping into data. The present and future: personalised treatment.
pharmaphorum
FEBRUARY 25, 2021
Chaired by the Genetic Alliance, the virtual meeting saw representatives from Scotland, England, Wales, and Northern Ireland discuss the implementation of the UK Government’s Rare Disease Framework. We now know that 80% of rare diseases have a genetic origin. Genomic technology, therefore, has a key role to play in our work,” he said.
STAT News
APRIL 3, 2023
When the long-awaited moment arrived, a nurse helped Adam Hess loosen a tiny plastic clamp on an intravenous line leading to the chest of his son, who lay asleep in a bed at Boston Children’s Hospital.
XTalks
MAY 26, 2023
DEB is a genetic disorder characterized by very fragile skin that rips and blisters easily even from minor friction (like rubbing or scratching) or injury, resulting in open wounds that are prone to skin infections and fibrosis. Vyjuvek is also the first drug approved to treat the disease and is Krystal’s first approved product.
Expert insights. Personalized for you.
98 
Let's personalize your content